UK Minister for Innovation introduces the Medicines and Medical Device 2019-20 bill
As the UK officially left the EU at the end [...]
New Chan Zuckerberg Initiative (CZI) program provides funding for rare disease advocacy groups
In recent years, there has been increased recognition of the [...]
When is compassionate use a viable treatment option?
Compassionate use refers to the use of an unapproved drug [...]
FDA launches new data-sharing app called CURE ID
The FDA, in collaboration with the NIH’s National Center for [...]
WEP Clinical donates food to the Food Bank of Central & Eastern North Carolina
As part of our continued efforts to give back [...]
Project Orbis: new collaborative program allows for concurrent drug approvals in participating countries
Earlier this year, the FDA announced the launch of Project [...]
Former Commissioner says FDA has money and mandate to accelerate use of RWE in drug approval process
Earlier this month, former FDA Commissioner, Scott Gottlieb, spoke about [...]
Acting FDA Commissioner, Dr. Sharpless, speaks at 2019 NORD Conference on Rare Diseases
Last week, the National Organization for Rare Disorders (NORD) held [...]
FDA to Provide Guidance Documents Relating to Patient Experience Data
As part of the 21st Century Cures Act, the FDA [...]
New UK Health Data Research Hubs
Although the UK is home to some of the world’s [...]